征稿已开启

查看我的稿件

注册已开启

查看我的门票

已截止
活动简介

ConferenceSeries Ltd Organises 300 International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, 50,000 reputed scientists as editorial board members and 5 million readers.

Why to attend??

  • Best platform to develop new partnership & collaborations.

  • Best location to speed up your route into every territory in the World.

  • 89% our conference attendees are the Key contact in their labs purchasing decisions.

  • Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.

  • Past exhibitor’s feedback reveals ample of enquiries perceived from the conference attendees.

  • Network development with both Academia and Business.

Why Singapore??

SINGAPORE, known as "the LION city," becomes a favourite destination because it is a global city and is a densely populated island with tropical flora,parks and gardens. Singapore is a global commerce,finance and transport hub.

Singapore is considered as an important center for higher education and harbours, healthcare,well reputed and prestigious colleges and Universities. Singapore conferences indeed play a vital role in promoting scientific information and ideas all over the world. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. They serve as a major center of attraction for reputed and highly affiliated global scientific leaders and provide an opportunity of conversing the various research highlights at an international podium.

Education: Education in Singapore consists of three stages primary,secondary and pre-university education.Singapore comprises of two main public universities which ranked among top 13 in the world: National University of Singapore and Nanyang Technological University. In all public schools English is the medium of instruction and communication.

Conference Highlights:

1.Virus & Viral Evolution,General Virology 

2.Viral Pathogenesis & Latency,Virulence 

3.Molecular & Genomic Virology

4.Vaccines & Antiviral Drugs

5.Viral Therapy & Viral Vectors

6.Viral Replication

7.Herpes Simplex Virus

8.Neuro Virology

9.Sexually Transmitted Viral Infections

10.Oncogenic Viruses

11.Viral Respiratory Infections

12.Current Trends and research in Virology

13.Serological Methods in Virology

14.Viral Bioweapon

15. Plant & Agricultural Virology

16. Viral hepatitis

17. Veterinary Virology

18. Aquatic Viral Disease

19. Mycology and its Diversity

20. Mycotoxins

21. Mycology and Ecology

22. Medical and Industrial Mycology

23. Food and Veterinary Mycology

24. Clinical Mycology and Mushrooms

25. Viral Haemorrhagic Fever

26. Transplant associated Viral Infections

Target Audience:

  • Scientists

  • Research Scholars

  • Associate Professors

  • Professors

  • Lecturers

  • M.Sc Students

  • Pharmaceutical Industries

  • Healthcare Industries

  • Directors of Associations and Societies

征稿信息

征稿范围

Track 1:Virus & Viral Evolution,General virology

  • Track 1-1Structure Based Virus Classification

  • Track 1-2Virions,Satellites & Hypothesis for the Origin of Virus

  • Track 1-3Replication Cycle and Application

  • Track 1-4Viral Quasisspecies

  • Track 1-5Error Threshold,Mutational Robustness & Cooperation

Track 2:Viral Pathogenesis & Latency,Virulence

  • Track 2-1Mechanisms of Viral Pathogenesis

  • Track 2-2Virulence Factors

  • Track 2-3Mechanisms of action in Viral Latency

  • Track 2-4Endotoxins and Exotoxins

  • Track 2-5Destructive Enzymes

  • Track 2-6Ramification

Track 3:Molecular and Genomic virology

  • Track 3-1Types of Viral Genomes

  • Track 3-2Types of Viral Spread

  • Track 3-3Capsid Type

  • Track 3-4Baltimore Classification

  • Track 3-5Viral Infections

  • Track 3-6Chemotherapeutic Index of an Antiviral Drug

 

Track 4:Vaccines and Antiviral drugs

  • Track 4-1Preventive Health and Pharmaceutical Drug

  • Track 4-2Types of Vaccines

  • Track 4-3Classification of Antiviral Drugs

  • Track 4-4Antiretroviral Drugs,Treatment and Adverse Effects

  • Track 4-5Monoclonal Antibodies and its applications

  • Track 4-6Hybridoma Development

  • Track 4-7HIV Post Exposure Prophylaxsis

Track 5:Viral Therapy and Viral Vectors

  • Track 5-1Branches of Viral Therapy

  • Track 5-2Virosomes,Influenza and Non Influenza Virosomes

  • Track 5-3Key Properties of Viral Vector

  • Track 5-4Viral Transformation

  • Track 5-5Types and Cellular Affects of Viral Infection.

  • Track 5-6Medical Applications

  • Track 5-7Types of Viral Vectors

  • Track 5-8Gene Therapy,Immunotherapy,Protozoal Virotherapy

Track 6:Viral Replication

  • Track 6-1Major Steps in Viral Replication Process

  • Track 6-2Baltimore Classification System

  • Track 6-3Ribosomal Frame Shifting

  • Track 6-4Reverse Transcriptase

  • Track 6-5Reverse Transcribing Virus

  • Track 6-6Retroviral Reverse Transcription

  • Track 6-7Replication Fidelity

Track 7:Herpes Simplex Virus

  • Track 7-1Types of Herpes Simplex Virus

  • Track 7-2Alzeheimer’s Disease

  • Track 7-3Multiplicity Reactivation

  • Track 7-4Applications of Herpes Simplex Virus

  • Track 7-5Virology in Herpes Simplex Virus

Track 8:Neuro Virology

  • Track 8-1Neurotropic Virus

  • Track 8-2Herpes Simplex Encephalitis

  • Track 8-3Mollaret’s Meningitis

  • Track 8-4Neuroimaging,Serology,Brain Biopsy

  • Track 8-5Research and Therapy in Neurovirology

  • Track 8-6Arbovirses causing neurological disorders

  • Track 8-7Rabies virus: diagnosis, management and prevention

Track 9:Sexually Transmitted Viral Infections

  • Track 9-1Causes of Sexually Transmitted Viral Infections

  • Track 9-2Pathophysiology of the disease

  • Track 9-3Epidemology and Management

  • Track 9-4Health Complications in Males and Females

  • Track 9-5Countermeasures and Prevention

Track 10:Oncogenic Virus

  • Track 10-1Gag-Onc Fusion Protein

  • Track 10-2Engineering Oncolytic Virus

  • Track 10-3Oncolytic Behaviour Wild Type Virus

  • Track 10-4Oncolytic Virus and Mechanism of action

  • Track 10-5Tumour Supressor Gene,Multiple Mutations,Protooncogene,Non-Mutagenic Carcinogens

  • Track 10-6Carcinogenesis,Cancer stem cell,Clonal Evolution

  • Track 10-7Oncogenes and its classification

  • Track 10-8Adult T-cell Leukemia and its medications

  • Track 10-9Chemotherapy,Haematopoietic Stem Cell Transplantation,Radiation Therapy

  • Track 10-10Hodgkin’s Lymphoma

  • Track 10-11HIV And its diagnosis

Track 11:Viral Respiratory Infections

  • Track 11-1Symptoms of VRI and Classification of Common Viral Respiratory Syndromes

  • Track 11-2Common Cold,Pneumonia Causes,Diagnosis and Treatment

  • Track 11-3Tuberculosis Causes ,Diagnosis, Treatment, Preventive Measures

  • Track 11-4Causes of Viral Respiratory Infections

  • Track 11-5Bronchiolities,Tonsilties Causes,Diagnosis and Treatment

  • Track 11-6Influenza Vaccines: Latest Update

Track 12:Current Trends and Research In Virology

  • Track 12-1Respiratory Syncytial Virus, Viral Load,Genotype

  • Track 12-2Human Enterovirus A71, Subgenotype B5 Importation

  • Track 12-3Bovine Foamy Virus,Infectious Clone,BT-as Promoter

  • Track 12-4Hand,Foot and Mouth Disease, Enterovirus A,Random PCR

  • Track 12-5Bombyxmori Bidensovirus,Genome Clone,Linear Co-Transfection,Virus Rescue

  • Track 12-6Automation in Virology

  • Track 12-7Next Generation Sequencing

  • Track 12-8Microarray Technology

  • Track 12-9Syndromic approach in Virology

Track 13:Serological Methods In Virology

  • Track 13-1RIA and Immunosorbet Assay

  • Track 13-2Elisa,Haemagluttination Inhibition Test,Neutralization,Complement Fixation Test

  • Track 13-3Limitations of Serological Diagnosis

  • Track 13-4Viral Genome Detection

  • Track 13-5Electron Microscopy and Antigen Detection

  • Track 13-6Virus Isolation, Single Radial Haemolysis

Track 14:Viral Bioweapon

  • Track 14-1Ebola Virus,Rift Valley Fever Virus

  • Track 14-2Japanese Encephalitis

  • Track 14-3Bioherbicides and Mycoherbicides

  • Track 14-4Bioterrorism and Biosurvelliance

  • Track 14-5Modern Bioweapon Operations

  • Track 14-6Identification of Bioweapons and Genetic Warfare

Track 15:Plant And Agricultural Virology

  • Track 15-1Overview,Structure,Transmission of Plant Viruses

  • Track 15-2Translation of Plant Viral Proteins

  • Track 15-3Grapevine-Leaf Roll Associated Virus

  • Track 15-4Bromomosaic,Tobacco Mosaic Virus

  • Track 15-5Cucumber Mosaic,Alfalfa Mosaic Virus

  • Track 15-6Rice Stripe,Fruit and Vegetable Virus

  • Track 15-7Serological Methods in Plant Virology

  • Track 15-8Mycovirology

Track 16:Viral Hepatitis

  • Track 16-1Types of Hepatitis and its Treatment

  • Track 16-2Diagnosis and Pathophysiology of Hepatitis

  • Track 16-3Symptoms,Complications and Preventive Measures of Hepatitis

  • Track 16-4Etiology,Epidemology,Prognosis of Hepatitis

  • Track 16-5Yellow Fever Virus

  • Track 16-6Non hepatitis viral infections involving liver

Track 17:Veterinary Virology

  • Track 17-1Animal Viruses of Agricultural Importance

  • Track 17-2Avian Viruses and Aquatic-Species Viruses

  • Track 17-3Principles of animal Virology

  • Track 17-4Host Virus Interactions,Pathogenesis and Prion Disease

  • Track 17-5Classification of Animal Viruses

  • Track 17-6West Nile Virus and Zoonoses Epidemology

  • Track 17-7Mad Cow’s Disease

Track 18:Aquatic Viral Disease

  • Track 18-1Koi Herpes Virus and Largemouth Bass Virus

  • Track 18-2Viral haemorrhagic septicaemia virus (VHSV) and Megalocytiviruses

  • Track 18-3Infectious haematopoietic necrosis virus and Viral Erythrocytic Necrosis (IHNV)

  • Track 18-4Channel Catfish Virus Disease and Epizootic Hematopoietic Necrosis

  • Track 18-5Viral Nervous Necrosis (Betanodaviruses) and Salmonid Alphaviruses

  • Track 18-6Infectious Pancreatic Necrosis and Infectious Salmon Anaemia

  • Track 18-7Diagnostics and Epidemology

Track 19:Mycology and its Diversity

  • Track 19-1Mushroom Hunting

  • Track 19-2Mycotoxicology

  • Track 19-3Pathogenic Fungi

  • Track 19-4Enzymes and their types

  • Track 19-5Mode of Nutrition

  • Track 19-6Source of Fungus

Track 20:Mycotoxins

  • Track 20-1Identification and Characterization of Mycotoxins

  • Track 20-2Production and Types of Mycotoxins

  • Track 20-3Mycoses and Mycotoxicoses

  • Track 20-4Fumonisins,Alfatoxin and Citrinin

  • Track 20-5Toxicology and Human Health

  • Track 20-6Trichothecenes,Patulin and Ochratoxin

Track 21:Mycology and Ecology

  • Track 21-1Fungal Ecology

  • Track 21-2Competition and Conservation of Fungi

  • Track 21-3Role of Fungi in Ecosystem

  • Track 21-4Mycelial and Fungus-Microbe Interaction

  • Track 21-5Population Dynamics and Hyphal Interactions

  • Track 21-6Advance Mycological Research

Track 22:Medical and Industrial Mycology

  • Track 22-1Fungal Diseases in Humans,Neonatals and Paediatrics

  • Track 22-2Antifungal Susceptibility and Resistance

  • Track 22-3Vaccinology for the Prevention of Fungal Infections

  • Track 22-4Mycopathology

  • Track 22-5Mycoproteins,Mycodiesel,Antibiotics and Vitamins

  • Track 22-6Fungi in Food,Beverages Baking Industry and Waste Treatment

  • Track 22-7Fermentation and Advancement in Industrial Mycology

  • Track 22-8Biomass

Track 23:Food and Veterinary Mycology

  • Track 23-1Mycotoxin Production in Foods

  • Track 23-2Food Ecology,Enumeration and Identification of Fungi in Foods.

  • Track 23-3Fungal Development

  • Track 23-4Fungal Zoonoses

  • Track 23-5Pathophysiology of Fungal Disease

  • Track 23-6Veterinary Pathogenic Fungi and Animal Mycoses

  • Track 23-7Antifungals in Animals

Track 24:Clinical Mycology and Mushrooms

  • Track 24-1Etymology,Identification,Classification and Morphology of Mushrooms

  • Track 24-2Edible,Toxic and Medicinal Mushrooms

  • Track 24-3Psychoactive Mushrooms and Mushroom Production

  • Track 24-4Epidemology and Phylogeny of Fungal Pathogens

  • Track 24-5Terminologies of Clinical Mycology

  • Track 24-6Direct Identification of Mycological Species

Track 25:Viral Haemorrhagic Fever

  • Track 25-1Symptoms and laboratory findings of VHF

  • Track 25-2Differential diagnosis of VHF

  • Track 25-3Management and Prevention of VHF

Track 26:Transplant associated Viral Infections

  • Track 26-1Causes of early, intermediate and late viral infections in transplant recipients

  • Track 26-2Monitoring of viral infections in donor and recipients

  • Track 26-3Prevention of viral infections in transplant recipients

留言
验证码 看不清楚,更换一张
全部留言
重要日期
  • 会议日期

    05月11日

    2017

    05月12日

    2017

  • 05月12日 2017

    注册截止日期

移动端
在手机上打开
小程序
打开微信小程序
客服
扫码或点此咨询